Clinical recommendation	Evidence Rating	References
Patients with HIV should be monitored for CD4+ lymphocyte and HIV RNA levels every three to six months.	C	7,8,26,28
Patients who are hepatitis A or B nonimmune at baseline should be vaccinated.	B	7,8,25
Tuberculosis prophylaxis should be given to patients with any of the following: history or symptoms of tuberculosis, a PPD of at least 5 mm, or a possible false-negative PPD.	C	7,8,25
Pneumocystis jiroveci prophylaxis with trimethoprim/sulfamethoxazole (Bactrim, Septra) should be initiated at CD4+ counts of less than 200 cells per mm3.	A	7,8,25
Women with HIV should have Pap smears every six months for the first year and, if normal, annual Pap smears thereafter.	C	7,8,25
High-risk patients with ongoing exposure should be checked annually for gonorrhea, chlamydia, syphilis, and hepatitis C.	C	7,8,25
[ corrected] Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.	B	7,8,25